Bionano Genomics (BNGO) Return on Invested Capital (2018 - 2026)

Bionano Genomics has disclosed Return on Invested Capital across 9 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.01% for Q1 2026 at Bionano Genomics, down from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2025 to a low of 0.02% in Q1 2024.
• The 5-year median for Return on Invested Capital is 0.01% (2023), against an average of 0.01%.
• Across the five-year window, Return on Invested Capital slipped 2 bps in 2024 and advanced 3 bps in 2025, its largest moves.
• Bionano Genomics' Return on Invested Capital stood at 0.0% in 2022, then plunged by 290 bps to 0.02% in 2023, then soared by 73 bps to 0.01% in 2024, then plunged by 33 bps to 0.01% in 2025, then dropped by 18 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.